Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Feb:32:1-11.
doi: 10.1016/j.ejon.2017.10.006. Epub 2017 Nov 7.

Hearing loss and tinnitus in survivors with chemotherapy-induced neuropathy

Christine Miaskowski  1 , Steven M Paul  2 , Judy Mastick  2 , Mark Schumacher  3 , Yvette P Conley  4 , Betty Smoot  3 , Gary Abrams  3 , Kord M Kober  2 , Steven Cheung  3 , Jennifer Henderson-Sabes  3 , Margaret Chesney  3 , Melissa Mazor  2 , Margaret Wallhagen  2 , Jon D Levine  3
Affiliations

Hearing loss and tinnitus in survivors with chemotherapy-induced neuropathy

Christine Miaskowski et al. Eur J Oncol Nurs. 2018 Feb.

Abstract

Purpose: The purpose of this study was to evaluate for differences in demographic, clinical, and pain characteristics, as well as measures of sensation, balance, perceived stress, symptom burden, and quality of life (QOL) among survivors who received neurotoxic chemotherapy (CTX) and who reported only chemotherapy-induced neuropathy (CIN, n = 217), CIN and hearing loss (CIN/HL, n = 69), or CIN, hearing loss, and tinnitus (CIN/HL/TIN, n = 85). We hypothesized that as the number of neurotoxicities increased, survivors would have worse outcomes.

Methods: Survivors were recruited from throughout the San Francisco Bay area. Survivors completed self-report questionnaires for pain and other symptoms, stress and QOL. Objective measures were assessed at an in person visit.

Results: Compared to survivors with only CIN, survivors with all three neurotoxicities were less likely to be female and less likely to report child care responsibilities. In addition, survivors with all three neurtoxicities had higher worst pain scores, greater loss of protective sensation, and worse timed get up and go scores. These survivors reported higher state anxiety and depression and poorer QOL. For some outcomes (e.g., longer duration of CIN, self-reported balance problems), significantly worse outcomes were found for the survivors with CIN/HL and CIN/HL/TIN compared to those with only CIN.

Conclusions: Our findings suggest that compared to survivors with only CIN, survivors with CIN/HL/TIN are at increased risk for the most severe symptom burden, significant problems associated with sensory loss and changes in balance, as well as significant decrements in all aspects of QOL.

Keywords: Balance; Chemotherapy; Hearing loss; Peripheral neuropathy; Survivor; Tinnitus.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest – The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Differences in the percentages of survivors with chemotherapy-induced neuropathy (CIN) and hearing loss versus the percentage of survivors with CIN, hearing loss, and tinnitus.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Al-Swiahb JN, Hwang ES, Kong JS, Kim WJ, Yeo SW, Park SN. Clinical and audiologic characteristics of patients with sensorineural tinnitus and its association with psychological aspects: an analytic retrospective study. Eur Arch Otorhinolaryngol. 2016;273:4161–4165. - PubMed
    1. Atas A, Agca O, Sarac S, Poyraz A, Akyol MU. Investigation of ototoxic effects of Taxol on a mice model. Int J Pediatr Otorhinolaryngol. 2006;70:779–784. - PubMed
    1. Bacon M, James K, Zee B. A comparison of the incidence, duration, and degree of the neurologic toxicities of cisplatin-paclitaxel (PT) and cisplatin-cyclophosphamide (PC) Int J Gynecol Cancer. 2003;13:428–434. - PubMed
    1. Bainbridge KE, Wallhagen MI. Hearing loss in an aging American population: extent, impact, and management. Annu Rev Public Health. 2014;35:139–152. - PubMed
    1. Bao T, Basal C, Seluzicki C, Li SQ, Seidman AD, Mao JJ. Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk. Breast Cancer Res Treat. 2016;159:327–333. - PMC - PubMed

MeSH terms